Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease
1Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
Summary
Adiponectin, IL-6, and CRP levels were elevated in chronic obstructive pulmonary disease (COPD) patients compared to healthy individuals. These biomarkers were inversely correlated with lung function in ever-smokers.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Inflammation Research
Background:
- Adiponectin, an anti-inflammatory adipokine, is implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD).
- Investigating adiponectin's role alongside other inflammatory markers is crucial for understanding COPD.
- Biomarkers like interleukin (IL)-6, IL-8, and C-reactive protein (CRP) are relevant in inflammatory conditions.
Purpose of the Study:
- To examine the association between adiponectin, IL-6, IL-8, and CRP levels and COPD.
- To compare these biomarker levels in individuals with and without COPD, focusing on ever-smokers.
Main Methods:
- Plasma levels of adiponectin, IL-6, IL-8, and CRP were quantified using commercial kits.
- The study included patients with COPD (n=71), healthy ever-smokers (n=62), and non-smokers (n=51).
Main Results:
- COPD patients exhibited significantly higher plasma adiponectin, IL-6, and CRP levels compared to both healthy ever-smokers and non-smokers (P < 0.001).
- Conversely, COPD patients showed lower plasma IL-8 levels than healthy ever-smokers.
- In ever-smokers (with or without COPD), adiponectin, IL-6, and CRP levels were inversely correlated with forced expiratory volume in 1 second (% predicted), even after adjusting for covariates.
Conclusions:
- Adiponectin may be associated with the pathogenesis of COPD.
- Elevated adiponectin, IL-6, and CRP, along with reduced IL-8, are potential indicators in COPD.
- The inverse correlation between these biomarkers and lung function highlights their clinical relevance in COPD.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.